Icelandirect

Icelandirect

Icelandirect Acquires SOMA LABS, Significantly Expanding Dosage Form Manufacturing Capabilities for Human and Pet Supplement Brands

Icelandirect, LLC (“Icelandirect”), a portfolio company of New Heritage Capital, has acquired SOMA LABS, a New Jersey-based supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026.  The acquisition is a direct investment in capability — expanding what Icelandirect can build, manufacture, and deliver for its clients across both the human nutrition and pet supplement markets.

Icelandirect

New Heritage Capital Invests in Icelandirect

BOSTON, MA – (BUSINESS WIRE) August 11, 2021 – New Heritage Capital (“Heritage”), a Boston-based private equity firm, is pleased to announce a new platform investment in Icelandirect (“Icelandirect” or the…